PURGENESIS - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 85183249
Serial Number
85183249
Registration Number
5080154
Word Mark
PURGENESIS
Status
700 - Registered
Status Date
2016-11-15
Filing Date
2010-11-23
Registration Number
5080154
Registration Date
2016-11-15
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
050325, 260129 - Other leaves. Helixes.
Published for Opposition Date
2016-08-30
Law Office Assigned Location Code
M50
Employee Name
KHAN, ASMAT A
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of the stylized word "PURGENESIS" with a stylized double helix containing a leaf design in the bottom opening of the double helix, appearing below the last "S" of "PURGENESIS".
Goods and Services
Extended release formulations, compositions and agents, namely, chemical additives and botanical extracts, namely, extracts coming from green plants, red plants, seaweed, micro and macro algae, brown algae and bacteria for use in the manufacture of human and veterinary medicinal products for the treatment of circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, oncologic, auto-immune or immune-related, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious, metabolic or central nervous system diseases, illnesses, disorders or conditions; extended release formulations, compositions and agents, namely, chemical additives and botanical extracts, namely, extracts coming from green plants, red plants, seaweed, micro and macro algae, brown algae and bacteria for use in the manufacture of human and veterinary medicinal products for the treatment of infertility, diabetes, and/or insulin imbalances; extended release formulations, compositions and agents, namely, chemical additives and botanical extracts, namely, extracts coming from green plants, red plants, seaweed, micro and macro algae, brown algae and bacteria for use in the manufacture of human and veterinary botanical products for the treatment of circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, oncologic, auto-immune or immune-related, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious, metabolic or central nervous system diseases, illnesses, disorders or conditions; extended release formulations, compositions and agents, namely, chemical additives and botanical extracts, namely, extracts coming from green plants, red plants, seaweed, micro and macro algae, brown algae and bacteria for use in the manufacture of human and veterinary botanical products for the treatment of infertility, diabetes, and/or insulin imbalances
Goods and Services
Non-medicated anti-aging creams and serums; astringents for cosmetic purposes, night cream, anti-wrinkle cream and lotion, barrier cream, namely, body cream
Goods and Services
Biofuels, namely, gaseous, solid and liquid fuel derived from plant and other biomass material
Goods and Services
Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention, treatment and alleviation of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of central nervous system disorders, diseases, conditions and ailments, namely, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, insomnia, mood disorders, bipolar disorder, seizure disorders and smoking habits or addictions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of neurological disorders, diseases, conditions and ailments, namely, brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, and cerebral palsy; pharmaceutical preparations and substances for the prevention, treatment and alleviation of psychiatric disorders, diseases, conditions and ailments, namely, mood disorders, anxiety disorders, panic disorders, bipolar disorders, cognitive disorders, schizophrenia, and depression; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the treatment and of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardiovascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of a symptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic orthrombolytic agents for the treatment of arterial, pulmonary and heart disease and afflictions and to restore arterial and vascular patency in order to prevent loss of tissue, limb and organ function; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of immunological disorders, diseases, conditions and ailments, namely, auto immune diseases, immunological deficiency syndromes, Acquired Immune Deficiency Syndrome (AIDS), immunological dysfunctions, hypersensitivity, allergies, tumors of the immunological organs; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of irritable bowel disorder, Crohn's disease and ulcerative colitis; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis, psoriasis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; and nutritional supplements, namely, vitamins, minerals, glucosamine and chondroitin; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals that control the solubility, compressibility and/or flow ability of drugs; oral extended release pharmaceuticals for the treatment of angina and hypertension; rapidly dissolving matrix pharmaceutical preparations to which may be added medicinal active ingredients for the treatment of dermatological, cardiopulmonary, respiratory, neurological, gastrointestinal related diseases and disorders for humans and for veterinary use; Botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; botanical naturopathic pharmaceutical preparations and substances for the cessation of smoking; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of sexually transmitted diseases; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of herpes; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of central nervous system disorders, diseases, conditions and ailments, namely, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, insomnia, mood disorders, bipolar disorder, seizure disorders and smoking habits or addictions; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of neurological disorders, diseases, conditions and ailments, namely, brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, and cerebral palsy; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of psychiatric disorders, diseases, conditions and ailments, namely, mood disorders, anxiety disorders, panic disorders, bipolar disorders, cognitive disorders, schizophrenia, and depression; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; botanical based anti-depressants; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of a symptomatic left ventricular dysfunction; botanical naturopathic pharmaceutical preparations and substances, namely, fibrinolytic orthrombolytic agents for the treatment of arterial, pulmonary and heart disease and afflictions and to restore arterial and vascular patency in order to prevent loss of tissue, limb and organ function; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of immunological disorders, diseases, conditions and ailments, namely, auto immune diseases, immunological deficiency syndromes, Acquired Immune Deficiency Syndrome (AIDS), immunological dysfunctions, hypersensitivity, allergies, tumors of the immunological organs; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation namely, pain relief medication and anti inflammatories; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of irritable bowel disorder, Crohn's disease and ulcerative colitis; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; botanical naturopathic pharmaceutical preparations and substances, namely, botanical skin care preparations for use in dermatology, namely, dermatitis, psoriasis and skin pigmentation diseases; botanical naturopathic pharmaceutical preparations and substances for use in oncology; botanical naturopathic pharmaceutical preparations and substances for use in ophthalmology; and botanical based nutritional supplements, namely, vitamins, minerals, glucosamine and chondroitin; botanical naturopathic pharmaceutical preparation and substance delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals that control the solubility, compressibility and/or flow ability of botanical preparations and substances; oral extended release botanical naturopathic pharmaceutical preparations and substances for the treatment of angina and hypertension; rapidly dissolving matrix botanical and naturopathic pharmaceutical preparations to which may be added botanical active ingredients for the treatment of dermatological, cardiopulmonary, respiratory, neurological, gastrointestinal related diseases and disorders for humans and for veterinary use; Rinse, namely, dandruff shampoo for controlling, preventing and treating dandruff; Cosmeceutical products, namely, general and advanced medicated hair care preparations; bone implants comprising live tissue, cosmetic surgery implants comprising live tissue
Goods and Services
Biosensors for the identification and determination of concentration of substances and other parameters of biological interest, namely, biosensors for detecting diseases, biologic indicators and biologic anomalies; Medical devices, namely, medical instruments for use in performing biopsies, diagnosing and treating cardiovascular, dermatological, cardiopulmonary, respiratory, neurological, gastrointestinal diseases and trauma, fractures, and conducting surgery for human and veterinary use; implantable and extra-corporeal medical devices for human and veterinary non-invasive or surgical repair, fixation, support, immobilization or stabilization of trauma, fractures, disease, disorders, conditions and ailments, namely, screws, plates, cerclage wiring, sutures, pacemakers, internal and external drug delivery systems, bone implants composed of artificial materials, stents, cosmetic surgery implants composed of artificial materials, artificial limbs, lenses for surgical implantation and hearing aids; Bone prostheses for human and veterinary use; Tooth and mouth care products, namely, gum stimulators, tongue scrapers, and palette and soft tissue cleaners in the nature of sprayers for cleaning gums and teeth used in dentists' offices during dental procedures
Goods and Services
Paper towels, facial tissues
Goods and Services
Retail and wholesale store services featuring advanced pharmaceutical products; Retail and wholesale store and consulting services featuring advanced botanical products; retail and wholesale store services featuring advanced biosensors; Retail and wholesale store services featuring advanced biofuels; Retail and wholesale store services featuring advanced cosmeceutical products; Retail and wholesale store services featuring advanced hair care, cosmetic, tooth and mouth care and body care products; and Retail and wholesale store services featuring advanced medical devices
Goods and Services
Manufacture of advanced pharmaceutical products to the order and/or specification of others; Manufacture of advanced botanical products to the order and/or specification of others; Manufacture of advanced biosensors to the order and specification of others; Manufacture of advanced biofuels to the order and specification of others; Manufacture of advanced cosmeceutical products to the order and specification of others; Manufacture of advanced hair care, cosmetic, tooth and mouth care and body care products to the order and specification of others; Manufacture of advanced medical devices to the order and specification of others
Goods and Services
Research and development in the field of pharmaceuticals; development of pharmaceutical preparations; clinical evaluation and testing of pharmaceutical compounds; research and development in the field of botanical naturopathic and pharmaceutical products; development of botanical naturopathic and pharmaceutical preparations; clinical evaluation and testing of botanical naturopathic and pharmaceutical products; scientific research and development in the field of biosensors; product development in the field of biosensors; Testing of new products for others in the field of biosensors; scientific research and development in the field of biofuels; Product development in the field of biofuels; testing of new products for others in the field of biofuels; scientific research and development in the field of cosmeceutical products; product development in the field of cosmeceutical products; testing of new products for others in the field of cosmeceutical products; scientific research and development in the field of hair care, cosmetic, tooth and mouth care and body care products; product development in the field of hair care, cosmetic, tooth and mouth care and body care products; testing of new products for others in the field of hair care, cosmetic, tooth and mouth care and body care products; scientific research and development in the field of medical devices; product development in the field of medical devices; testing of new products for others in the field of medical devices
Goods and Services
Licensing of pharmaceutical compounds; licensing of botanical products; licensing of biosensors; licensing of biofuels; licensing of cosmeceutical products; licensing of hair care, cosmetic, tooth and mouth care and body care products; licensing of medical devices
Pseudo Mark
PURE GENESIS
Classification Information
International Class
003 - Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices. - Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices.
US Class Codes
001, 004, 006, 050, 051, 052
Class Status Code
6 - Active
Class Status Date
2010-11-29
Primary Code
003
Current Trademark Owners
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
11 - 1st New Owner Before Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
GEORGE A. PELLETIER, JR.
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing DateApplication NumberCountryForeign Priority Claim In
2010-11-121503440CanadaTrue
2010-11-121503440CanadaFalse
Trademark Events
Event DateEvent Description
2010-11-26NEW APPLICATION ENTERED IN TRAM
2010-11-29NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2010-11-30NOTICE OF DESIGN SEARCH CODE MAILED
2011-02-14ASSIGNED TO EXAMINER
2011-02-21NON-FINAL ACTION WRITTEN
2011-02-21NON-FINAL ACTION E-MAILED
2011-02-21NOTIFICATION OF NON-FINAL ACTION E-MAILED
2011-08-18TEAS RESPONSE TO OFFICE ACTION RECEIVED
2011-08-18CORRESPONDENCE RECEIVED IN LAW OFFICE
2011-08-19TEAS/EMAIL CORRESPONDENCE ENTERED
2011-09-29SUSPENSION LETTER WRITTEN
2011-09-29LETTER OF SUSPENSION E-MAILED
2011-09-29NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
2012-04-03ASSIGNED TO LIE
2012-04-03SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
2012-05-10SUSPENSION INQUIRY WRITTEN
2012-05-10INQUIRY TO SUSPENSION E-MAILED
2012-05-10NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
2012-11-12TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
2012-11-14CORRESPONDENCE RECEIVED IN LAW OFFICE
2012-11-14TEAS/EMAIL CORRESPONDENCE ENTERED
2012-11-14SUSPENSION LETTER WRITTEN
2012-11-14LETTER OF SUSPENSION E-MAILED
2012-11-14NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
2013-05-20SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
2013-06-26SUSPENSION INQUIRY WRITTEN
2013-06-26INQUIRY TO SUSPENSION E-MAILED
2013-06-26NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
2013-12-19TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
2013-12-30CORRESPONDENCE RECEIVED IN LAW OFFICE
2013-12-30TEAS/EMAIL CORRESPONDENCE ENTERED
2014-01-02SUSPENSION LETTER WRITTEN
2014-01-02LETTER OF SUSPENSION E-MAILED
2014-01-02NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
2014-07-02SUSPENSION INQUIRY WRITTEN
2014-07-02INQUIRY TO SUSPENSION E-MAILED
2014-07-02NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
2014-12-03TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
2014-12-10CORRESPONDENCE RECEIVED IN LAW OFFICE
2014-12-10TEAS/EMAIL CORRESPONDENCE ENTERED
2015-01-08SUSPENSION LETTER WRITTEN
2015-01-08LETTER OF SUSPENSION E-MAILED
2015-01-08NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
2015-05-13AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
2015-07-14SUSPENSION INQUIRY WRITTEN
2015-07-14INQUIRY TO SUSPENSION E-MAILED
2015-07-14NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
2015-12-14TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
2015-12-18CORRESPONDENCE RECEIVED IN LAW OFFICE
2015-12-18TEAS/EMAIL CORRESPONDENCE ENTERED
2016-01-08NON-FINAL ACTION WRITTEN
2016-01-08NON-FINAL ACTION E-MAILED
2016-01-08NOTIFICATION OF NON-FINAL ACTION E-MAILED
2016-06-17TEAS RESPONSE TO OFFICE ACTION RECEIVED
2016-06-22CORRESPONDENCE RECEIVED IN LAW OFFICE
2016-06-22TEAS/EMAIL CORRESPONDENCE ENTERED
2016-07-19EXAMINERS AMENDMENT -WRITTEN
2016-07-19EXAMINERS AMENDMENT E-MAILED
2016-07-19NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2016-07-19EXAMINER'S AMENDMENT ENTERED
2016-07-20DATA MODIFICATION COMPLETED
2016-07-20APPROVED FOR PUB - PRINCIPAL REGISTER
2016-07-26LAW OFFICE PUBLICATION REVIEW COMPLETED
2016-08-10NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2016-08-30PUBLISHED FOR OPPOSITION
2016-08-30OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2016-11-15REGISTERED-PRINCIPAL REGISTER
2021-10-13ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
2021-11-15COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED